If switching from tirzepatide to retatrutide, start retatrutide at 2 mg regardless of your previous tirzepatide dose and titrate up on the standard schedule
healthcare professionals should review concomitant diabetes medicines before and during treatment Delayed gastric emptying as with other GLP-1-based therapies, retatrutide may slow gastric emptying, which could affect the absorption of some oral medicines
Consider these research findings: Biofilm formation: Bacterial biofilms can form in chronic nummular lesions, contributing to treatment resistance [3] Altered drug penetration: The thick, scaly (hyperkeratotic) nature of chronic lesions can reduce the absorption of topical medications [13] Neurogenic inflammation: The density of nerve fibers containing Substance P, a neuropeptide involved in inflammation and itching, is significantly increased in nummular eczema lesions [14] Most frustrating is the rebound phenomenon that can occur after discontinuing topical steroids, which can lead to a dependency cycle [15]
The injection sites are identical: abdomen, thigh, and upper arm
, (Mildronate) TMAO,
But there has been concern that they induce loss of muscle and other components of lean body mass along with fat